Business Wire

iSAT Africa and SES Networks to Provide Reliable 4G Services in East Africa via O3b mPOWER

15.7.2021 09:50:00 EEST | Business Wire | Press release

Share

Communities living across the eastern most peninsula of Africa will be able to enjoy 4G services on their mobile phones following a three-year partnership agreement signed by fixed satellite solution and professional service provider, iSAT Africa and SES, the leader in global content connectivity solutions. The two companies announced today that this new service will be available first via SES’s O3b medium earth orbit (MEO) constellation to subsequently migrate and expanded to SES’s next-generation MEO system, O3b mPOWER, in 2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210714005981/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

iSAT Africa and SES Networks to Provide Reliable 4G Services in East Africa via O3b mPOWER (Photo: Business Wire)

iSAT Africa is well-established in the region for embracing innovative mobile internet connectivity solutions for unconnected rural communities in Africa. Through SES’s highly-flexible and scalable O3b mPOWER system that can deliver low-latency high-speed connectivity services from tens of megabits to multiple gigabits per second to a single site, iSAT Africa will be able to quickly scale its network to meet anticipated extensive connectivity demands. The fibre-like connectivity will equipe iSAT Africa to enable local mobile operators to deploy 4G services to close the digital divide. iSAT Africa is among the first companies in Africa to sign up for O3b mPOWER.

According to the GSMA 2020 report, mobile coverage has been expanding in Sub-Saharan Africa quickly; 3G coverage expanded to 75% compared to 63% in 2017, while 4G doubled to nearly 50% compared to 2017. However, the coverage gap in Sub-Saharan Africa remains the highest globally as it is home to 67% of the world’s population not covered by mobile broadband. This is because attempts to deploy 4G networks in sparsely-populated rural and remote areas continue to be an economic challenge. With telcos and internet service providers increasingly seeking innovative, cost-effective yet reliable connectivity solutions, SES’s MEO satellite-based MEF-certified service that can ensure seamless interconnectivity with any network is an ideal solution.

“At iSAT Africa, we don’t just believe in delivering connectivity to everyone across Africa. It’s also about delivering differentiated, cost-effective and reliable services that will enable various businesses to expand. This agreement represents a leap towards achieving that mission with iSAT Africa being able to deliver 4G services to communities and businesses located in underserved areas. As long-term partners of SES, we are confident this innovative solution will enable us to offer differentiated connectivity services to our telco customers,” said Rakesh Kukreja, Founder and Managing Director at iSAT Africa.

John-Paul Hemingway, CEO of SES Networks said, “We will be able to revolutionise the connectivity capabilities of mobile operators across Africa together through this agreement with iSAT Africa. The O3b and O3b mPOWER systems will easily enable the deployment of 4G services and high-performance networks for cloud applications regardless of where they are across the region. The enhanced flexibility and scalability of O3b mPOWER will truly connect Africans living in underserved areas in the most economically viable manner.”

Follow us on:

TwitterFacebookYouTubeLinkedInInstagram

Read our Blogs >
Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,200 channels and has an unparalleled reach of 361 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.

About iSAT Africa

iSAT Africa, a fast-growing communication service provider in Africa and Middle East, is a UAE based company whose mission is to transform the way Africa gets and stays connected with the rest of the world. iSAT’s unique connectivity solutions deliver efficiency, reliability and affordability for Data, Internet, Voice and Video solutions . These customized solutions serve broadcast and media organizations, multinationals, major ISPs, Governmental and Non-Governmental organizations as well as Tier 1 telecom operators.

With its network of partners and service providers, iSAT Africa is able to satisfactorily deliver end-to-end solutions, turn-key solutions and managed services to it’s customers/ partners within the shortest time possible whilst adhering to agreed upon service level agreements.

iSAT’s Satellite Solutions, backed by powerful satellites, teleport and data infrastructure, latest technologies and inhouse human expertise is very unique in the industry. It is against this background that iSAT Africa partners with other leaders within the telco space in a bid to adequately meet its customers ever growing demand for telecommunication services across the African continent.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information:
Suzanne Ong
External Communications
Tel. +352 710 725 500
suzanne.ong@ses.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye